γ-secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets

As high-risk neuroblastoma (NB) has a poor prognosis, new therapeutic modalities are needed. We therefore investigated the susceptibility of NB cells to γ-secretase inhibitor I (GSI-I). NOTCH signaling activity, the cellular effects of GSI-I and its mechanisms of cytotoxicity were evaluated in NB ce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Principais autores: Dorneburg, Carmen, Goß, Annika V., Fischer, Matthias, Roels, Frederik, Barth, Thomas F.E., Berthold, Frank, Kappler, Roland, Oswald, Franz, Siveke, Jens T., Molenaar, Jan J., Debatin, Klaus-Michael, Beltinger, Christian
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Priority Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5325329/
https://ncbi.nlm.nih.gov/pubmed/27588497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11715
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados